The makers of Tylenol are pushing back against proposed changes to the medication's safety label following a petition from an anti-vaccine advocacy group.
The U.S. Food and Drug Administration received a petition from the Informed Consent Action Network, an anti-vaccine nonprofit, requesting a more detailed warning that includes language stating use during pregnancy increases the risk of neurodevelopmental disorders.
RELATED STORY | Scientist behind autism study cited by Trump admin paid $150K by plaintiffs suing Tylenol manufacturer
The petition was filed the same day President Donald Trump held a press conference claiming a link between autism and Tylenol's main ingredient, acetaminophen, despite disputed science.
Tylenol's maker, Kenvue, commented on the petition, calling the proposed changes "arbitrary, capricious and contrary to law."
The company added that acetaminophen is one of the most studied medicines in history and carries fewer risks than other pain relievers.
RELATED STORY | What medical experts say pregnant women need to know about Tylenol, leucovorin and autism
This story was reported on-air by a journalist and has been converted to this platform with the assistance of AI. Our editorial team verifies all reporting on all platforms for fairness and accuracy.
